Despite the current pandemic, our support for Swiss startups wanting to internationalize continues. We’re excited to announce that for the second time this year, we’re taking our swissnex Startup Bootcamp online, making our Demo Day available for audiences worldwide. This bootcamp’s cohort has a strong healthcare focus, and we’re happy to announce a new partnership with Swiss Healthcare Startups. The two winners of their Booster Program won an exclusive participation to our Fall bootcamp for which all seven finalist startups went through a challenging selection process, and target the US market.
Join us online for virtual demos, pitches, a unique opportunity to meet the startups one-on-one, and mingle with an international audience on October 22nd!
This event will take place on Zoom, and the networking sessions will take place on Remo. To ensure the best event experience on Remo, please make sure to:
- Join from a laptop ideally. If that is not an option, join from a tablet. If that is not an option, you can join from a mobile phone, but you might experience bugs because the mobile version is still in beta.
- Remo works best on Google Chrome (best) or on Firefox (second best), try to avoid other browsers if possible.
- Depending on where you are, there may be local restrictions and you may have to use a VPN to connect.
- Remo link
09:00am — Welcome
09:10am — Round 1 round of Startup Pitches (3min pitches / 3min Q&A)
09:35am — Networking Break (10min)
09:45am — Round 2 Startup round of Pitches (3min pitches / 3min Q&A)
10:15am — Virtual Demo Tables and Networking
11:15am — End
06:00pm — Welcome
06:10pm — Round 1 Startup Pitches (3min pitches / 3min Q&A)
06:35pm — Networking Break (10min)
06:45pm — Round 2 Startup round of Pitches (3min pitches / 3min Q&A)
07:15pm — Virtual Demo Tables and Networking
08:15pm — End
ASPIVIX | Mathieu HORRAS, Co-founder & CEO | aspivix.com
Every year, more than 80M women worldwide experience pain, bleeding and tissue tear when undergoing common gynecological procedures that require uterus access. This trauma is generated by the Cervical Tenaculum, an instrument with sharp hooks that pinch the cervix to generate traction. ASPIVIX is changing that by developing a next-generation vacuum-based cervical device that delivers the same maneuverability as the tenaculum without the reported patient trauma. This device is ideal to help address unplanned pregnancies, considered one of the most significant global public health issues, by increasing the adoption of Intrauterine Contraceptive Devices (IUD), the most effective reversible contraceptive option available today. ASPIVIX empowers women and makes them free to choose their contraception option without fear. Find them on Facebook, Instagram, Linkedin, Twitter, and YouTube.
Auxivo AG | Volker Bartenbach, Co-founder & CEO. Michael Stucky, Co-founder & Chairman. Fabio Gobbo, Business Developer | auxivo.com
JAMIE & I | Antonia Bolla, Founder | jamieandi.shop
Welcome to Your Personal Online Boutique with Sustainable Designers you’ll LOVE! Curated by Jamie, your personal artificially intelligent online stylist who curates your personal online boutique with a curated selection of sustainable designers tailored to your style. Follow them on Instagram, and Linkedin.
MYLEG | Giacomo Valle, Postdoctoral Researcher at ETHZ | my-leg.com
MYLEG is a non-invasive sensory feedback to improve Mobility and to promote cognitive prosthesis integration in people with leg amputation.
Neurosoft Bioelectronics develops implantable medical devices to interface with the brain and spinal cord to treat patients suffering from neurological disorders. Our main USP is that we are the only ones to have been able to combine extremely soft materials that match the mechanical properties of the nervous tissues with high-density electrodes. Thanks to these unique features, we can access some locations of the brain that are impossible to reach surgically otherwise. Our preliminary animal data also suggest that our soft electrodes reduce dramatically inflammation when implanted. Follow them on Linkedin and Twitter.
Optimo Medical AG | Harald P. Studer, CEO & Alexander van der Mey, CCO | optimo-medical.com
Optimo Medical AG is specialized in bio-mechanical analyses and simulation of the anterior eye. Since the companies founding in 2015, the team has built a steady reputation as the leading company in virtual trials for the anterior eye segment, and a global technology leader in patient specific astigmatism management. Follow them on Linkedin.
Scailyte uses single cell technologies and AI to discover biomarkers for diseases in oncology and immunology. We have a number of patented biomarker signatures which we currently are developing into clinical diagnostic applications for hospitals and subsequently patients. Follow them on Linkedin.
Danielle DeLancey is an investor at Wilmot Ventures, a family investment fund supporting early-stage companies led by exceptional entrepreneurs. At Wilmot, she focuses on complex technologies that seek to solve problems in behind the times markets. She’s passionate about working with portfolio companies on establishing company culture and solid internal processes that allow them to effectively scale. Prior to joining Wilmot, Danielle was the Chief of Staff at the San Francisco Bay Area Super Bowl 50 Host Committee where she managed the internal operations of the organizing entity responsible for Super Bowl 50 planning and production. Danielle joined as the first staff member of the committee to manage the day-to-day logistics of the bid effort, resulting in the awarding of the milestone Super Bowl 50 to the region by NFL ownership. Prior to her work at the Host Committee, Danielle worked managing large-scale product launches for an education technology start-up & as an analyst at the American Institutes for Research focusing on data analysis and education finance reform. She started her career as a Teach for America corp member, where she spent two years as a science teacher in rural North Carolina. Danielle earned a bachelor degree in organizational development with an emphasis in leadership effectiveness from Vanderbilt University followed by a master’s degree in policy from the Harvard Graduate School of Education.
Anne DeGheest pioneered the HealthTech or Digital Health space as a healthcare executive, an entrepreneur, angel investor, corporate advisor and mentor capitalist. She is the founder of HealthTech Capital and MedStars. Since she founded MedStars in 1986, she has been a corporate development advisor to large healthcare companies and a mentor capitalist specializing in investing and mentoring early stage companies in healthcare. Her life science portfolio companies have grown into major disruptive companies that have generated over $18 billion in market value. Anne founded in 2010 HealthTech Capital, a group of private investors dedicated to funding and mentoring new “HealthTech” startups to decrease healthcare cost and empower patients. MBA from Harvard and a Master in Business Engineering from University of Brussels.
Aimée LaFont Leifer is a partner at Calibrate Ventures, where she invests in and supports companies with a focus on automation (across sectors and technologies – from HealthTech to AgTech to Manufacturing and beyond). She serves as an Independent Board Member of Broadly and an angel investor in, board member of, and advisor to various early-stage companies including health technology, job placement, wellness, real estate, and consumer packaged goods companies. Previously, she was Vice President, Business Development at Weave HQ and before that at Intuit (INTU), where she served as Director of Business Development, Health, and also as Head of Health Division, Demandforce (an Intuit company). Prior to Intuit’s acquisition of Demandforce Aimée built, grew and ran the Health Division of Demandforce as Director, Business Development and Senior Manager of Business Development. Previously, she was an Associate at Bay Hills Capital Management and Sterling Stamos, two Bay Area-based Private Equity Fund-of-Funds. She holds an MBA from The University of Chicago Booth School of Business and a BA from the University of California, Los Angeles.